Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review

• Published in: Familial cancer 2024-06, Vol.23 (2), p.121-132
• Main Authors: Afaya, Agani, Kim, Sung-Won, Park, Hyung Seok, Lim, Myong Cheol, Jung, Mi Sook, Nam, Eun Ji, Park, Ji Soo, Jeong, Joon, Ryu, Jai Min, Kim, JiSun, Kim, Jihye, Kim, Minkyoung, Jin, Juhye, Han, Jeehee, Kim, Soo Yeon, Park, Sun-Young, Katapodi, Maria C., Kim, Sue
• Format: Article
• Language: English
• Subjects: Biomedical and Life Sciences; Biomedicine; Breast; Breast cancer; Breast Neoplasms - diagnosis; Breast Neoplasms - genetics; Breast Neoplasms - psychology; Cancer Research; Communication; Decision making; Epidemiology; Family - psychology; Female; Genetic Predisposition to Disease - psychology; Genetic screening; Genetic Testing; Hereditary Breast and Ovarian Cancer Syndrome - diagnosis; Hereditary Breast and Ovarian Cancer Syndrome - genetics; Hereditary Breast and Ovarian Cancer Syndrome - psychology; Human Genetics; Humans; Medical personnel; Ovarian cancer; Ovarian Neoplasms - diagnosis; Ovarian Neoplasms - genetics; Ovarian Neoplasms - psychology; Review
• ISSN: 1389-9600; 1573-7292; 1573-7292
• DOI: 10.1007/s10689-024-00379-y

Despite increased awareness and availability of genetic testing for hereditary breast and ovarian cancer (HBOC) syndrome for over 20 years, there is still significant underuse of cascade genetic testing among at-risk relatives. This scoping review synthesized evidence regarding psychosocial barriers and facilitators of family communication and/or uptake of cascade genetic testing in relatives from HBOC families. Search terms included ‘hereditary breast and ovarian cancer’ and ‘cascade genetic testing’ for studies published from 2012–2022. Through searching common databases, and manual search of references, 480 studies were identified after excluding duplications. Each article was reviewed by two researchers independently and 20 studies were included in the final analysis. CASP, RoBANS 2.0, RoB 2.0, and MMAT were used to assess the quality of included studies. A convergent data synthesis method was used to integrate evidence from quantitative and narrative data into categories and subcategories. Evidence points to 3 categories and 12 subcategories of psychosocial barriers and facilitators for cascade testing: (1) facilitators (belief in health protection and prevention; family closeness; decisional empowerment; family support, sense of responsibility; self-efficacy; supportive health professionals); (2) bidirectional concepts (information; perception of genetic/cancer consequences; negative emotions and attitude); and (3) barriers (negative reactions from family and negative family dynamics). Healthcare providers need to systematically evaluate these psychosocial factors, strengthen facilitators and alleviate barriers to promote informed decision-making for communication of genetic test results and uptake of genetic testing. Bidirectional factors merit special consideration and tailored approaches, as they can potentially have a positive or negative influence on family communication and uptake of genetic testing.